62 related articles for article (PubMed ID: 3671385)
1. Synergism between a phosphodiesterase inhibitor and modulators of thromboxane formation on thrombin-induced sudden death in rabbits.
Smith EF; Olson RW
Prog Clin Biol Res; 1987; 242():241-6. PubMed ID: 3671385
[No Abstract] [Full Text] [Related]
2. Comparison of the effects of a thromboxane synthase inhibitor or prostacyclin in combination with a phosphodiesterase inhibitor for prevention of experimental thrombosis and sudden death in rabbits.
Smith EF; Egan JW
J Pharmacol Exp Ther; 1987 Jun; 241(3):855-60. PubMed ID: 3298621
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.
Lefer AM; Okamatsu S; Smith EF; Smith JB
Thromb Res; 1981 Aug; 23(3):265-73. PubMed ID: 6795758
[No Abstract] [Full Text] [Related]
4. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats.
Mistry M; Nasjletti A
J Pharmacol Exp Ther; 1990 Apr; 253(1):90-4. PubMed ID: 2139470
[TBL] [Abstract][Full Text] [Related]
5. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion-prevention model.
LeGrand EK; Rodgers KE; Girgis W; Campeau JD; Dizerega GS
J Invest Surg; 1995; 8(3):187-94. PubMed ID: 7547726
[TBL] [Abstract][Full Text] [Related]
7. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
Welch WJ; Wilcox CS; Dunbar KR
Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
[TBL] [Abstract][Full Text] [Related]
8. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat.
Welch WJ; Wilcox CS
J Clin Invest; 1988 Jun; 81(6):1843-9. PubMed ID: 2968365
[TBL] [Abstract][Full Text] [Related]
9. Effect of thromboxane synthase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis.
Shebuski RJ; Storer BL; Fujita T
Thromb Res; 1988 Dec; 52(5):381-92. PubMed ID: 3146820
[TBL] [Abstract][Full Text] [Related]
10. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
11. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M
J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187
[TBL] [Abstract][Full Text] [Related]
12. Selective thromboxane synthase inhibition does not increase in vivo synthesis of prostacyclin in healthy humans.
Vesterqvist O; Gréen K; Henriksson P; Rasmanis G; Edhag O
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():165-8. PubMed ID: 1825536
[No Abstract] [Full Text] [Related]
13. Identification of a nonendothelial cell thromboxane-like constrictor response and its interaction with the renin-angiotensin system in the aorta of spontaneously hypertensive rats.
Dyer SM; Taylor DA; Bexis S; Hime NJ; Frewin DB; Head RJ
J Vasc Res; 1994; 31(1):52-60. PubMed ID: 8274625
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of thromboxane responses in the airway of the cat by SQ29,548 and OKY 1581.
Kadowitz PJ; McNamara DB; Tilden SJ; Hyman AL; Underwood DC
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():535-8. PubMed ID: 2526533
[No Abstract] [Full Text] [Related]
15. Biology and biochemistry of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
[No Abstract] [Full Text] [Related]
16. Endothelin-1 releases endothelium-derived endoperoxides and thromboxane A2 in porcine coronary arteries with regenerated endothelium.
Park SJ; Lee JJ; Vanhoutte PM
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):872-8. PubMed ID: 11270983
[TBL] [Abstract][Full Text] [Related]
17. Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension.
Mistry M; Nasjletti A
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():207-10. PubMed ID: 2526469
[TBL] [Abstract][Full Text] [Related]
18. The combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding.
Kawai H; Tamao Y
Thromb Res; 1995 Dec; 80(5):429-34. PubMed ID: 8588204
[No Abstract] [Full Text] [Related]
19. Thromboxane A2 does not play a role in the development or maintenance of hypertension in spontaneously hypertensive rats.
Stegmeier K; Sponer G; Pill J
Prog Clin Biol Res; 1987; 242():253-7. PubMed ID: 2959964
[No Abstract] [Full Text] [Related]
20. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
